Global Breast Imaging Market: Snapshot
The World Health Organization (WHO) revealed breast cancer to be the second most ubiquitous tumors among women. It additionally studied that over 200,000 new instances of cancer are registered each year over the globe. Breast imaging advances are utilized to get high-goals images of breast tissues. These imaging modalities, for example, ionizing and non-ionizing imaging advancements, help in the early recognition and finding of breast sicknesses, particularly breast cancer in women.
According to the analysts at TMR, the worldwide breast cancer imaging market is anticipated to reach an expected valuation of US$4.06 billion by 2019, as against its worth of US$1.84 billion which was evaluated in 2012, in this way growing at a 12% CAGR during the period of 2013 and 2019.
Breast MRI Segment to Grow at an Unprecedented Rate
The report segments the worldwide breast imaging market into breast ultrasound, mammography, tomosynthesis, atomic imaging, breast MRI, and others (breast thermography and bioelectric imaging), in terms of the type of technology used. Of these, mammography utilizes low-force X-beams to create two-dimensional images of breast tissues. Amid reviews, it was uncovered that roughly 44 million women in the U.S. alone experience mammography consistently, out of whom 36% women are recommended for a second analytic test. A large number of these women turn to ultrasound breast screening, which has developed as a promising breast imaging innovation to analyze breast cancer among women.
Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1371
Today, MRI is utilized for the identification of a wide range of breast conditions. Their specificity in tumor location has prompted MRI being one of the main breast disease recognition devices. Breast MRI procedure utilizes magnetic waves to capture breast tissue images, while ultrasound utilizes sound waves with a recurrence higher than the human hearing extent. Atomic imaging instruments, for example, positron emission tomography (PET) is utilized for restaging and assessment of repetitive breast cancer. Various PET imaging devices are accessible in the market and their propelled variations are as of now being worked on to decide their viability.
Ubiquity of Chronic Ailments in North America to Push Region to Fore
North America commanded the global breast imaging market in the past and trend is expected to continue in the coming years. The modern medicinal services offices in this region coupled with presence of reimbursement over therapeutic medications encouraged the utilization of breast imaging. Also, the pervasiveness of the chronic medical conditions in this region is considerably higher than worldwide normal, along these lines contributing towards the development of this region to a large extent.
Asia Pacific is foreseen to see the swift growth over the duration of forecast. Steady government arrangements to enhance medicinal services framework alongside financial advancements are foreseen to oversee factors for development.
The players in the market are endeavoring to keep up their footprint in the global market. Expanding rivalry by methods for mechanical enhancements and new product development prompting reduction in product cost are foreseen to be the positive results for the market support.
In 2013, Hologic, Inc. anchored a solid position in the worldwide market because of its vital understandings and associations combined with the new product releases. Keeping in mind the end goal to fuel the opposition, key players are vivaciously engaged with presenting better than ever innovation viewpoints to their items.
Request a Sample of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1371
Prominent vendors profiled by the report include Siemens Healthcare Corporation, Aurora Imaging Technologies, Philips Healthcare, FUJIFILM SonoSite, Inc., GE Healthcare Ltd., and SonoCine Inc.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
Email: [email protected]